Impact of age and induction therapy on outcome of 180 adult patients with acute myeloid leukemia; retrospective analysis and literature review

Impact of age and induction therapy on outcome of 180 adult patients with acute myeloid leukemia; retrospective analysis and literature review

The prognosis of acute myeloid leukemia (AML) remains poor. Among 180 patients, the median age was 53 (14-88) years. The overall 2-year disease free survival (DFS) was 28.6% (+/- 3.4), 47.7% (+/- 6.6%) for ≤ 40, 23.6% (+/- 5.8%) for 41–60 and 11.7% (+/- 4.2%) for ≥61 (p< 0.0001). The overall 2-ye...

Full description

Bibliographic Details
Main Authors: Khadega A. Abuelgasim, Bandar Albuhayri, Rayan Munshi, Areej Al Mugairi, Bader Alahmari, Giamal Gmati, Hind Salama, Mohsen Alzahrani, Ayman Alhejazi, Ahmed Alaskar, Moussab Damlaj
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:Leukemia Research Reports
Subjects:
Acute myeloid leukemia
High-risk cytogenetics
Standard induction
Elderly
Allogeneic hematopoietic stem cell transplantation
Online Access:http://www.sciencedirect.com/science/article/pii/S2213048920300121

Internet

http://www.sciencedirect.com/science/article/pii/S2213048920300121

Similar Items